Risk Factor Adapted Treatment of Hodgkin’s Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany-Reference-Cited by-同舟云学术

Risk Factor Adapted Treatment of Hodgkin’s Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany

Published:1989 Issue: Volume: Page:205-213
ISSN:0080-0015
Container-title:New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease
language:
Short-container-title:

Author:

Schellong G.,Hörnig I.,Schwarze E. W.,Wannenmacher M.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-83781-4_22

Reference7 articles.

1. Brämswig JH, Heermann E, Heimes U, Schlegel W, Nieschlag E, Schellong G (1987) Testicular function in boys treated for Hodgkin’s disease: results of a longitudinal and cross-sectional study in 52 postpubertal boys (abstr). Acta Endocrinol (Copenh) 114: 20

2. Breu H, Schellong G, Grosch-Wörner I, Jobke A, Riehm H, Treuner J. Schwarze EW, Wannenmacher M (1982) Abgestufte Chemotherapie und reduzierte Strahlendosis beim Morbus Hodgkin im Kindesalter-Ein Bericht über 170 Patienten der kooperativen Therapiestudie HD-78. Klin Pädiatr 194: 233–241

3. Schellong G, Strauch ST, Waubke AK, Brandeis W, Pawlowsky J, Schwarze EW, Riehm H, Langermann HJ, Wannenmacher M (1985) Combined modality treatment with reduced chemotherapy and radiotherapy, and selective splenectomy, in children with Hodgkin’s disease. In: Cavalli F, Bonnadonna G, Rozencweig M (eds) Malignant lymphomas and Hodgkin’s disease. Experimental and therapeutic advances. Martinus Nijhoff, The Hague, pp 617–626

4. Schellong G, Waubke-Landwehr AK, Langermann HJ, Riehm HJ, Brämswig J, Ritter J (1986a) Prediction of splenic involvement in children with Hodgkin’s disease. Significance of clinical and intraoperative findings. A retrospective statistical analysis of 154 patients in the German therapy study DAL-HD-78. Cancer 57: 2049–2056

5. Schellong G, Brämswig J, Ludwig R, Gerein V, Jobke A, Jürgens H, Kabisch H, Stollmann B, Weinel P, Gadner H, Schwarze EW, Wannenmacher M (1986b) Kombinierte Behandlungsstrategie bei über 200 Kindern mit Morbus Hodgkin: Abgestufte Chemotherapie, Involved-Field-Bestrahlung mit erniedrigten Dosen und selektiver Splenektomie. Ein Bericht der kooperativen Therapiestudie DAL-HD-82. Klin Pädiatr 198: 137–146

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies;Pediatric Blood & Cancer;2011-10-28

2. Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: the experience of the German–Austrian pediatric multicenter trial DAL-HD-90;Radiotherapy and Oncology;2002-02

3. Hodgkin disease in children: Results of a prospective randomized trial in a single institution in Argentina;Medical and Pediatric Oncology;1997-12

4. 11 Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric study group;Baillière's Clinical Haematology;1996-09

5. Hodgkin’s Disease;Radiation Therapy in Pediatric Oncology;1994